Swanhill Capital

Swanhill Capital is an investment partnership dedicated to actively pursue investments in healthcare companies, excluding biotechnology and pharmaceutical ventures. They are committed to long-term capital appreciation and to expanding their investment portfolio. They opportunistically participate as a minority or majority investor by infusing capital in companies at all phases of their life cycle from a seed round to a traditional LBO. Swanhill Capital was founded in 2007 and is headquartered in New York.

David M. Perkal

Managing Partner and Founder

2 past transactions

1DOC3

Seed Round in 2021
1doc3 is a e-health platform that connects 490 million of Spanish speaking people with licensed and trusted doctors. Users find personalized answers to their health related questions. Doctors build their online reputation, find new patients and create the biggest health related questions and answers curated database in Spanish. The Platform is available via web, App, SMS and USSD, allowing the entire population to have access to a Doctor no matter where they are, or even if they don't have internet access.

Cohero Health

Seed Round in 2015
Cohero Health offers a proprietary connected health platform for those with respiratory illness. Its sensor-based technology and engaging platform improve medication adherence and care coordination between patients and their care providers. The company offers a suite of tools and technology comprises form flexible inhaler sensors, mobile spirometers, to track real-time adherence and lung function, and a mobile application accessible on iPhone, iWatch, and Android. Cohero Health was founded in 2013 and is headquartered in New York.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.